Membrane incorporation of 22-hydroxycholesterol inhibits chemokine receptor activity

Experimental Cell Research

Volumn 285, Issue 2, 2003, Pages 268-277

  Nguyen, Dzung H ^a   Taub, Dennis D ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Chemokine; Chemokine receptors; Cholesterol; Lipid rafts; Oxysterol; Signaling; T cells

Indexed keywords

22 HYDROXYCHOLESTEROL; CHEMOKINE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; OXYSTEROL; STROMAL CELL DERIVED FACTOR 1ALPHA;

ARTICLE; CALCIUM MOBILIZATION; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INCUBATION TIME; LIGAND BINDING; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

EID: 0037403329     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00063-6     Document Type: Article

References (49)

1. Mackay C.R. Chemokines immunology's high impact factors . Nature Immunol. 2:2001;95-101.
2. Mellado M., Rodriguez-Frade J.M., Manes S., Martinez A.C. Chemokine signaling and functional responses the role of receptor dimerization and TK pathway activation . Annu. Rev. Immunol. 19:2001;397-421.
3. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor . Science. 272:1996;872-877.
4. Navenot J.M., Wang Z.X., Trent J.O., Murray J.L., Hu Q.X., DeLeeuw L., Moore P.S., Chang Y., Peiper S.C. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding . J. Mol. Biol. 313:2001;1181-1193.
5. Gershengorn M.C., Osman R. Minireview insights into G protein-coupled receptor function using molecular models . Endocrinology. 142:2001;2-10.
6. Samson M., LaRosa G., Libert F., Paindavoine P., Detheux M., Vassart G., Parmentier M. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 272:1997;24934-24941.
7. Galvez T., Duthey B., Kniazeff J., Blahos J., Rovelli G., Bettler B., Prezeau L., Pin J.P. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J. 20:2001;2152-2159.
8. Maggio R., Barbier P., Colelli A., Salvadori F., Demontis G., Corsini G.U. G protein-linked receptors pharmacological evidence for the formation of heterodimers . J. Pharmacol. Exp. Ther. 291:1999;251-257.
9. Rodriguez-Frade J.M., Mellado M., Martinez A.C. Chemokine receptor dimerization two are better than one . Trends Immunol. 22:2001;612-617.
10. Percherancier Y., Planchenault T., Valenzuela-Fernandez A., Virelizier J.L., Arenzana-Seisdedos F., Bachelerie F. Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor. J. Biol. Chem. 276:2001;31936-31944.
11. Bannert N., Craig S., Farzan M., Sogah D., Santo N.V., Choe H., Sodroski J. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J. Exp. Med. 194:2001;1661-1673.
12. Blanpain C., Wittamer V., Vanderwinden J.M., Boom A., Renneboog B., Lee B., Le Poul E., El Asmar L., Govaerts C., Vassart G., Doms R.W., Parmentier M. Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. J. Biol. Chem. 276:2001;23795-23804.
13. Gimpl G., Burger K., Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry. 36:1997;10959-10974.
14. Pang L., Graziano M., Wang S. Membrane cholesterol modulates galanin-GalR2 interaction. Biochemistry. 38:1999;12003-12011.
15. Sooksawate T., Simmonds M.A. Effects of membrane cholesterol on the sensitivity of the GABA(A) receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology. 40:2001;178-184.
16. Nguyen D.H., Taub D. CXCR4 function requires membrane cholesterol implications for HIV infection . J. Immunol. 168:2002;4121-4126.
17. D.H. Nguyen, D. Taub, Cholesterol is essential for macrophage inflammatory protein 1-beta binding and conformational integrity of CC chemokine receptor 5, Blood 99 (2000) 4298-4306.
18. Schroepfer G.J. Jr. Oxysterols modulators of cholesterol metabolism and other processes . Physiol. Rev. 80:2000;361-554.
19. Tam S.P., Ramharack R. The effect of 25-hydroxycholesterol on the regulation of apolipoprotein E mRNA levels and secretion in the human hepatoma HepG2. Atherosclerosis. 95:1992;137-146.
20. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis. 142:1999;1-28.
21. Zhou Q., Wasowicz E., Handler B., Fleischer L., Kummerow F.A. An excess concentration of oxysterols in the plasma is cytotoxic to cultured endothelial cells. Atherosclerosis. 149:2000;191-197.
22. Kummerow F.A., Scott Cook L., Wasowicz E., Jelen H. Changes in the phospholipid composition of the arterial cell can result in severe atherosclerotic lesions. J. Nutr. Biochem. 12:2001;602-607.
23. Kucuk O., Stoner-Picking J., Yachnin S., Gordon L.I., Williams R.M., Lis L.J., Westerman M.P. Inhibition of cytolytic T lymphocyte activity by oxysterols. Lipids. 29:1994;657-660.
24. Christ M., Ji Y.H., Moog C., Pannecoucke X., Schmitt G., Bischoff P., Luu B. Antitumor activity of oxysterols. Effect of two water-soluble monophosphoric acid diesters of 7 beta-hydroxycholesterol on mastocytoma P815 in vivo. Anticancer Res. 11:1991;359-364.
25. O'Callaghan Y.C., Woods J.A., O'Brien N.M. Oxysterol-induced cell death in U937 and HepG2 cells at reduced and normal serum concentrations. Eur. J. Nutr. 38:1999;255-262.
26. Aupeix K., Weltin D., Mejia J.E., Christ M., Marchal J., Freyssinet J.M., Bischoff P. Oxysterol-induced apoptosis in human monocytic cell lines. Immunobiology. 194:1995;415-428.
27. Moog C., Deloulme J.C., Baudier J., Revel M.O., Bischoff P., Hietter H., Luu B. Membrane-related oxysterol function preliminary results on the modification of protein kinase C activity and substrate phosphorylation by 7 beta,25-dihydroxycholesterol . Biochimie. 73:1991;1321-1326.
28. Moog C., Ji Y.H., Waltzinger C., Luu B., Bischoff P. Studies on the immunological properties of oxysterols in vivo actions of 7,25-dihydroxycholesterol upon murine peritoneal cells . Immunology. 70:1990;344-350.
29. Kucuk O., Stoner-Picking J., Yachnin S., Gordon L.I., Williams R.M., Lis L.J., Westerman M.P. Inhibition of NK cell-mediated cytotoxicity by oxysterols. Cell. Immunol. 139:1992;541-549.
30. Tian L., Cai Q., Bowen R., Wei H. Effects of caloric restriction on age-related oxidative modifications of macromolecules and lymphocyte proliferation in rats. Free Radicals Biol. Med. 19:1995;859-865.
31. Shigenaga M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA. 91:1994;10771-10778.
32. Osada K., Minehira K., Inoue S., Nakamura S., Yamada K., Sugano M. Effect of oxidized cholesterol on age-associated changes to immune parameters in spleen lymphocytes and peritoneal exudate cells derived from rats. Biosci. Biotechnol. Biochem. 64:2000;1047-1051.
33. Minehira K., Inoue S., Nonaka M., Osada K., Yamada K., Sugano M. Effects of dietary protein type on oxidized cholesterol-induced alteration in age-related modulation of lipid metabolism and indices of immune function in rats. Biochim. Biophys. Acta. 1483:2000;141-153.
34. Lee B., Sharron M., Blanpain C., Doranz B.J., Vakili J., Setoh P., Berg E., Liu G., Guy H.R., Durell S.R., Parmentier M., Chang C.N., Price K., Tsang M., Doms R.W. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J. Biol. Chem. 274:1999;9617-9626.
35. Gomez-Mouton C., Abad J.L., Mira E., Lacalle R.A., Gallardo E., Jimenez-Baranda S., Illa I., Bernad A., Manes S., Martinez A.C. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc. Natl. Acad. Sci. USA. 98:2001;9642-9647.
36. Slee E.A., Zhu H., Chow S.C., MacFarlane M., Nicholson D.W., Cohen G.M. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:1996;21-24.
37. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., Virelizier J.L., Baggiolini M., Sykes B.D., Clark-Lewis I. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16:1997;6996-7007.
38. Gupta S.K., Pillarisetti K., Thomas R.A., Aiyar N. Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha implications for development of selective CXCR4 antagonists . Immunol. Lett. 78:2001;29-34.
39. Monteclaro F.S., Charo I.F. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J. Biol. Chem. 271:1996;19084-19092.
40. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241.
41. Huh H.Y., Pearce S.F., Yesner L.M., Schindler J.L., Silverstein R.L. Regulated expression of CD36 during monocyte-to-macrophage differentiation potential role of CD36 in foam cell formation . Blood. 87:1996;2020-2028.
42. Geng Y., Kodama T., Hansson G.K. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler. Thromb. 14:1994;798-806.
43. Witztum J.L., Steinberg D. The oxidative modification hypothesis of atherosclerosis does it hold for humans? Trends Cardiovasc. Med. 11:2001;93-102.
44. Fulop T. Jr., Douziech N., Goulet A.C., Desgeorges S., Linteau A., Lacombe G., Dupuis G. Cyclodextrin modulation of T lymphocyte signal transduction with aging. Mech Ageing Dev. 122:2001;1413-1430.
45. Douziech N., Seres I., Larbi A., Szikszay E., Roy P.M., Arcand M., Dupuis G., Fulop T. Modulation of human lymphocyte proliferative response with aging. Exp. Gerontol. 37:2002;369-387.
46. Morre D.M., Lenaz G., Morre D.J. Surface oxidase and oxidative stress propagation in aging. J. Exp. Biol. 203:2000;1513-1521.
47. Roth G.S., Ingram D.K., Lane M.A. Caloric restriction in primates and relevance to humans. Ann. N. Y. Acad. Sci. 928:2001;305-315.
48. Miquel J. Can antioxidant diet supplementation protect against age-related mitochondrial damage? Ann. N.Y. Acad. Sci. 959:2002;508-516.
49. Girotti A.W. Photosensitized oxidation of membrane lipids reaction pathways, cytotoxic effects, and cytoprotective mechanisms . J. Photochem. Photobiol. B. 63:2001;103-113.